atropine (OT-101 ophthalmic solution) / Ocumension Therap - LARVOL DELTA

Study of Atropine Sulfate Eye Drops(0.01%) in Treating Near-work-induced Transient Myopia in Children (clinicaltrials.gov) - P3 | N=148 | Completed | Sponsor: Ocumension Therapeutics (Suzhou) Co., Ltd

New P3 trial • Ophthalmology

Study of OT-101 in Treating Myopia (clinicaltrials.gov) - P3 | N=678 | Active, not recruiting | Sponsor: Ocumension (Hong Kong) Limited | Recruiting ➔ Active, not recruiting

Enrollment closed • Ophthalmology • Pediatrics

Study of OT-101 in Treating Myopia (clinicaltrials.gov) - P3 | N=678 | Recruiting | Sponsor: Ocumension (Hong Kong) Limited | Trial completion date: May 2026 ➔ Apr 2027 | Trial primary completion date: Apr 2026 ➔ Mar 2027

Trial completion date • Trial primary completion date • Ophthalmology • Pediatrics